Hypertriglyceridemia: Danger for the arteries;Hypertriglyceridemie: Danger pour les arteres

Presse Medicale

Volumn 28, Issue 36, 1999, Pages 2011-2017

  Chanu, B ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMORBIDITY; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; REVIEW; ARTERIOSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; MALE; PATHOPHYSIOLOGY; RISK FACTOR;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, VLDL; MALE; RISK FACTORS; TRIGLYCERIDES;

EID: 0033589412     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Jones HB, Gofman JW, Lindgren FT et al. Lipoproteins in atherosclerosis. Am J Med 1951 ; 1:358-66.
2. Hamsten A, Waaldius G, Dahlen G, Johansson B, De Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986 ; 59:223-35
3. Hulley SB, Roseman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 1980 ; 302:1383-9.
4. Tatami R, Mabuchi H, Ueda K et al. Intermediate-density lipoprotein and angiographically determined coronary artery disease. Circulation 1981 ; 64:1174-84.
5. Steiner G, Schwartz L, Shumak S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987 ; 75:124-30.
6. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985 ; 71:881-8.
7. Tornvall P, Karpe F, Carlson LA, Hamsten A. Relations of low density lipoprotein subclasses to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991 ; 90:67-80.
8. Tornvall P, Bavenholm P, Landou C, De Faire U, Hamsten A. Relationship of angiographically defined coronary artery disease to plasma levels and composition of apolipoprotein B containing lipoproteins in patients with myocardial infarction at young age. Circulation 1993 ; 88:2180-9.
9. Drexel H, Amann FW, Beran J et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994 ; 90:2230-5.
10. Hamsten A, Walldius G, Szamosi A, Dahlen G, De Faire U. Relationship of angiographically defined coronary artery disease to serum lipoprotein in young survivors of myocardial infarction. Circulation 1986 ; 73:1097-110.
11. Olsson AG, Carlson LA, Erikson U et al. Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidemia. Lancet 1982 ; 1:1311.
12. Krauss RM, Lindgren FT, Williams PT et al. Intermediate density lipoproteins and progression of coronary artery disease in hypercholesterolemic men. Lancet 1987 ; ii:62-6.
13. Blankenhorn DH, Alaupovic P, Wickman E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts:lipid and non lipid factors. Circulation 1990 ; 81:470-6.
14. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993 ; 88:2762-70.
15. Hodis HN, Mack W, Azen SP et al. Triglyceride and cholesterol rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994 ; 90:42-9.
16. Ericsson CG, Hamsten A, Nilsson J, et al. An angiographic evaluation of the effects of bezafibrate on the progression of coronary artery disease in young mal post infarction patients. The bezafibrate coronary atherosclerosis intervention trial (BECAIT) (submitted for publication).
17. Avins AL, Haber RJ, Hulley SB. The statut of hypertriglyceridemia as a risk factor for coronary heart disease Clinic Lab Med 1989 ; 9:153-68.
18. Fontbonne A, Eschwege E, Cambien F et al. Hypertriglyceridemia as a risk factor for coronary disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11 years follow up of the Paris Prospective Study. Diabetologia 1989 ; 32:300-4.
19. Castelli WP. Cholesterol and lipids in the risk of coronary heart disease. The Framingham Heart Study. Can J Cardiol 1988 ; 4:5A.
20. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993 ; 153:2209-16.
21. Criqui MH, Heiss G, Cohn R et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993 ; 17:1220-5.
22. Cambien F, Jacqueson A, Richard JL et al. Is the level of serum triglyceride a significant predictor of coronary death in normocholesterolemic subjects ? Am J Epidemiol 1986 ; 124:624-32.
23. Lehto S, Ronnemaa T, Haffner SM et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with non-insulin-dependant diabetes. Diabetes 1997 ; 46:1354-9.
24. Lehto S, Ronnemaa T, Pyorala K, Laasko M. Predictors of stroke in middle-aged patients with non-insulin-dependant diabetes. Stroke 1996 ; 27:63-8.
25. Hokanson JE, Austin MA. Plasma triglyceride is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol. A meta-analysis of population based prospectives studies. J Cardiovasc Risk 1996 ; 3:213-19.
26. Stampfer MJ, Krauss RM, Ma J et al. A prospective study of triglyceride level, low density lipoprotein particle diameter and risk of myocardial infarction. JAMA 1996 ; 276:882-8.
27. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study:Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence in coronary heart disease. N Engl J Med 1987 ; 317:1237-45.
28. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen male study. Circulation 1998 ; 97:1027-8.
29. Miller M, Selder A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: the Baltimore coronary observational long term study. J Am Coll Cardiol 1998 ; 31:1252-7.
30. Assman G, Schulte H, Von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996 ; 77:1179-84.
31. Luc G, Fievet C, Arveiler D et al. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. J Lipid Res 1996 ; 37:508-17.
32. Zilversmit DB. Atherogenesis:a postprandial phenomenon. Circulation 1979 ; 60:473-85.
33. Van Ienten BJ, Fogelman AM, Jackson RJ et al. Receptor-mediated uptake of remnant lipoproteins by chylomicron-laden human monocytes-macrophages. J Biol Chem 1985 ; 260:8783-8.
34. Giaturco S, Bradley WA, Nozaki S, Vega GL, Grundy SM. Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia. Arterioscler Thromb 1993 ; 13:472-81.
35. Rapp JH, Lespine A, Hamilton RL et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apoprotein B immunosorption from human atherosclerotic plaque. Arteriosder Thromb 1994 ; 14:1767-74.
36. Karpe F, Bell M, Bjorkegren J, Hamsten A Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labelling and simultaneous mesurement of apolipoprotein B-48 and B-100. Arterioscler Thromb Vasc Biol 1995 ; 15:199-207.
37. Ross AC, Minick CR, Zilvermist DB. Equal atherosderosis in rabbit feed cholesterol free, low fat diet or cholesterol supplemented diet Atherosclerosis 1978 ; 29:301-5.
38. Barr DP, Russ EM, Eder HA. Protein lipid relationship in human plasma. Am J Med 1951 ; 11:480-93.
39. Reed DM, Strong JP, Resch J, Hayashi T. Serum lipids and lipoproteins are predictors of atherosclerosis: an autopsy study. Arteriosclerosis 1989 ; 9:560-4.
40. Solberg LA, Strong JP. Risk factors and atherosclerosic lesions:a review of autopsy studies. Arteriosclerosis 1983 ; 3:187-98.
41. Holme I, Solberg LA, Weissfeld L, Helgeland A, Hjermann I, Leren P, Strong JP, Williams OD. Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Am J Cardiol 1985 ; 55:40-7.
42. Kannel WB, Castelli WP, Gordon R, Mcnamara PM. Serum cholesterol, lipoproteins and the risk of coronary heart disease. The Framingham Study. Ann Intern Med 1971 ; 14:1-8.
43. Gordon DI, Probstfield JL, Garrison RJ et al. High density lipoprotein cholesterol and cardiovascular disease four prospective american studies. Circulation 1989 ; 79:8-15.
44. Deckelbaun RJ, Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure composition in low and high density lipoprotein. Arteriosclerosis 1984 ; 4:225-31.
45. MC Namara JR, Jenner JL, Li Z, Wilson PW, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992 ; 12:1284-90.
46. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1991 ; 32:1741-53.
47. Nordoy A, Stron E, Gjesdal K. The effect of alimentary hyperlipidemia and primary hypertriglyceridemia on platelet in man. Scand J Haemat 1974 ; 12:3229-40.
48. Aberg H, Lithell H, Selinus I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-years follow-up of Uppsala primary preventive study. Atherosclerosis 1985 ; 54:89-97.
49. Miller GJ, Walter SJ, Stirling Y, et al. Assay of factor VII activity by two techniques:evidence for increase conversion of VII to alpha VIIa in hyerlipidemia with possible implications for ischaemic heart disease. Br J Haematol 1985 ; 59:249-58.
50. Scarabin PY, Bara L, Samama M, Orssaud G. Further evidence that activated factor VII is related to plasma lipids. Br J Haematol 1985 ; 61:186-7.
51. Junker R, Heinrich J, Schulte H, Van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997 ; 17:1539-44.
52. Carvalho de Sousa J, Bruckert E, Giral P et al. Plasma facteur VII, triglycerides concentration and fibrine degradation products in primary hyperlipidemia: a clinical and laboratory study. Haemostasis 1989 ; 19:83-90.
53. Carvalho de Sousa J, Bruckert E, Giral Ph et al. Coagulation facteur VII and plasma triglycerides. Haemostasis 1989 ; 75:125-30.
54. Constantino M, Merskey C, Kudzma DJ, Zucker MB. Increase activity of vitamine K dependent clotting factor in human hyperlipoproteinemia. Association with cholesterol and triglycerides levels. Thromb Haemostas 1977 ; 38:465-74.
55. Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamine K - dependent clotting factors with cholesterol and triglycerides in healthy young adult Arterioscler Thromb 1994 ; 14:1737-40.
56. Juhan-vague I, Thompson SC, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrom. A study of 1500 patients with angina pectoris. Arteriosler Thromb 1993, 13:1865-73.
57. Ecat angina pectoris study group. ECAT Angina Pectoris Study:baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3 000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993 ; 14:8-17.
58. Hirago T, Shimada M, Tsukada T, Murase T. Hypertriglyceridemia but not hypercholesterolemia, is associated with the alterations of fibrinolytic system. Harm Metab Res 1996 ; 28: 603-6.
59. Metha J, Metha P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease:correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987 ; 9:263-8.
60. Dwyer JH, Rieger-Ddakorerwa ER, Semmer NK, Fuch R, Lipper P. Low level cigarette smoking and longitudinal change in serum cholesterol among adolescents: The Berlin Bremen Study. JAMA 1988 ; 259:2857-62.
61. Philips NR, Havel RJ, Kane JP. Levels and interrelationship of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco and beverages containing caffeine. Arteriosclerosis 1981 ; 1:13-24.
62. Stamford BA, Matter S, Fell RD et al. Cigarette Smoking, Exercise and High Density Lipoprotein Cholesterol. Atherosclerosis 1984 ; 52:73-83.
63. Bruckert E, Jacob N, Lamaire I et al. Relationship between smoking status and serum lipids in a hyperlipidemic population and analysis of possible confounding factors. Clin Chem 1992 ; 38:1698-1705.